Shenzhen New Industries Biomedical Engineering's (SHE:300832) detection kit obtained a medical device registration certificate from the drug administration of China's Guangdong Province, according to the company's disclosure on the Shenzhen Stock Exchange.
The certificate, which is valid until June 4, 2029, is for the Chinese biomedical technology company's α1-Microglobulin Assay Kit (Latex Immunoturbidimetry), the Wednesday disclosure added.
Shares of the company slipped nearly 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments